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Background: Despite increasing importance of
patient self-management, little is known about
their own perceptions and treatment goals.
Objectives: The aim of this explorative study
was to examine what diabetic patients perceive as
most concerning and what their own treatment
goals are.
Methods: A 23-item anonymous questionnaire
was distributed among type 1 diabetic patients
treated with and without an insulin pump and in-
sulin treated type 2 diabetic patients in the out-
patient clinic of a University Hospital. 86% of the
questionnaires were returned (n = 124).
Results: In open-ended questions, patients in
all three groups together felt mostly restricted by
their loss of freedom (24%), the dietary restric-
tions (17%) and the need to measure blood glucose
(17%). Patients treated with an insulin pump wor-
ried more about hypoglycaemia and less about
dietary restrictions. In closed-ended questions,
patients were mostly concerned about hypogly-
caemia and developing complications. However,
the main treatment goal of both groups together
was long-term good blood glucose control (63%).
Further patient goals were the prevention of com-
plications (27%) and the preservation of a good
quality of life. Quality of life was a more important
goal for type 1 diabetic patients (29%) than for
type 2 diabetic patients (0%). Patients thought that
blood glucose control was more important for
their physicians (main treatment goal for 86%)
than for themselves.
Conclusion: Insulin treated patients with dia-
betes spontaneously express concerns about their
actual quality of life and daily hassles and mention
long-term worries after explicit questioning. For
their main treatment goals they choose mainly
long-term goals. According to the patients, physi-
cians tend to overestimate blood glucose control.
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Diabetes mellitus affects more than 170 mil-
lion people worldwide. The psychological burden
of this disease is substantial and quality of life can
be markedly reduced in affected subjects [1, 2].
Insulin treatment seems to further influence the
impact of the disease on quality of life [2]. On the
other side, patient empowerment and self-man-
agement can increase their satisfaction and quality
of life [3, 4] as well as metabolic control [5–7].
Therefore, diabetes care is moving towards more
patient-centred care. Individual tailoring of the
treatment goals to patients’ own goals potentiates
this autonomy [8]. The patient-driven implemen-
tations of their own treatment goals are influenced
by their disease perception and their attitude
towards the disease, which are both necessary
components for a behavioural change [9, 10]. Un-
fortunately, little is known about patients’ subjec-
tive disease perception and diabetes-related con-
cerns, eg which components of their disease bother
them. The available diabetes-specific question-
naires like the Diabetes Illness Representation
Questionnaire (and its generic form, the Illness
Perception Questionnaire), the Personal Model of
Diabetes Interview, the Problem Areas in Diabetes
Scale, the Diabetes Quality of Life Questionnaire
and the Diabetes-specific Quality-of-Life Scale)
cover disease perceptions to some extent, but focus
more on illness representation, illness beliefs,
quality of life and perceived health consequences
and less on the question which aspect of the dis-
ease or its management patients perceive as most
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concerning or restricting [11–15]. In addition,
these questionnaires use closed-ended questions.
One study that examined patients’ perceptions
showed that over 80% of patients worried about
developing complications, while about a third
worried about the occurrence of hypoglycaemic
events. Gender and the presence of complications
influenced these perceptions [16]. Regarding pa-
tients’ own treatment goals, there is hardly any
published data. It is also unclear if treatment goals
differ from disease perceptions. One study demon-
strated that patients found good glucose control,
flexibility, avoidance of late complications as well
as of severe hypoglycaemia to be very important
goals [12]. In this study, almost all queried items
were given a high priority, and causes that influ-
enced these goals or differences in gender or type
of diabetes were not investigated. Secondly, the
questionnaire was not anonymous, and thus more
vulnerable to biases such as social desirability.
We therefore performed this explorative study
to learn about the subjective disease-related per-
ceptions, concerns and treatment goals of type 1
diabetic patients treated with and without an in-
sulin pump and insulin treated type 2 diabetic pa-
tients. We also were interested whether patients
are satisfied with their medical care in an Outpa-
tient Clinic of a University Hospital in Switzerland
and whether there is a discrepancy between their
own and their physicians’ treatment goals.
Patients and methods
Patients
A self-report questionnaire was distributed to all Ger-
man-speaking patients with type 1 and insulin treated type
2 diabetes in the outpatient clinic of the University Hos-
pital of Basel within a four-week period. Anonymity was
ensured. 86% of the questionnaires were answered and re-
turned in a prestamped envelope addressed to the primary
investigator. The demographic characteristics of the
patients are described in table 1. The majority of these
patients have type 1 diabetes (n = 102) and most of them
underwent a group-training course where they learn to
adjust insulin dosage to food intake and daily activity
(Course in Functional Insulin Therapy [FIT]). Thus, it is
assumed that they are knowledgeable about their meta-
bolic control and/or the presence of complications. 
Patients were divided in three groups: type 1 diabetic
patients treated with an insulin pump, type 1 diabetic pa-
tients treated without an insulin pump (practicing FIT or
basis-bolus therapy, ie basal/mealtime insulin with dose-
adjustments according to the blood glucose values) and in-
sulin treated type 2 diabetic patients. None of the type 2
diabetic patients was treated with an insulin pump.
The human research ethics committee of the Univer-
sity of Basel approved the study.
Questionnaire development
A 23-item questionnaire was devised to obtain rou-
tine sociodemographic information about the age, sex and
level of education of the patients as well as information
about their type of diabetes, their disease duration, their
metabolic control and the eventual presence and number
of diabetic complications. The three main areas of inter-
est included patients’ disease perception, their treatment
goals and provider satisfaction. As it was difficult to find
validated measures that covered all factors of interest for
this study, we added some own questions and assessed the
questionnaire for its reliability. Wherever possible, ques-
tions were used from the Diabetes Quality of Life Ques-
tionnaire [11]. The questions were tested among 5 patients
and three diabetes educators prior to being used and were
found to be comprehensible.
Disease perceptions
We specifically included open-ended questions to be
able to include a maximal range of patients’ perceptions
and treatment goals and to diminish pleasing bias. We first
asked whether their diabetes impairs their quality of life
and then, in open-ended questions, which components of
their diabetes concern them mostly or impair their qual-
ity of life. Subsequently all answers were categorised as
follows: loss of freedom, dietary restrictions, measuring
blood glucose, insulin injections, fear of hypoglycaemia,
fear of complications, worries about loss of efficiency, need
for discipline, need to carry around utensils or dependence
on foreign body (patients with insulin pumps), general
stress, mental stress, general health.
We investigated in closed-ended questions the influ-
ence of diabetes on their life and their concerns using a 
5-point scale ranging from 0 (“does not concern me at all”
or “never concerns me”) to 4 (“concerns me very much”
or “always concerns me”) for the following diabetes-
related categories: dietary restrictions, measuring blood
glucose, insulin injections, fear of hypoglycaemia, fear of
complications, influence of diabetes on personal relations,
need to lose weight, need to be physically active and finan-
cial concerns.
Treatment goals
Regarding treatment goals, the following question
was asked: “What is your most important goal regarding
your diabetes?” Patients could mention up to two treat-
ment goals. Furthermore, they were asked to state the
main treatment goals they thought that their physicians
had. If two treatment goals were mentioned, both of them
were included in the analysis. Subsequently all answers
were categorised as follows: good glucose control, preven-
tion of complications, preservation of quality of life, avoid-
ance of hypoglycaemia, discipline, independence, self-
efficiency, good medical care, weight reduction. 
Provider satisfaction
The following items regarding the physicans’ role in
patient-centred care were investigated in closed-ended
questions, where patients could answer yes, no or partly:
“Does your physician know your treatment goals and is
he/she responsive to them? Does your physician answer
your questions and spend enough time with you? Are you
generally satisfied with your physician?” 
Statistical analysis 
Data are expressed as means (SD) unless indicated
otherwise. Principal component analyses with subsequent
varimax-rotation were used to assess the structure of the
questionnaire. Cronbach’s α was computed as a reliability
measure. However, the reduction of all perceptions to one
or two single factors would result in a loss of necessary
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clinical information. Therefore, all single items were used
for further analyses.
As this was an explorative study and we were not test-
ing hypotheses, a sample size calculation was not appro-
priate and no p-values are reported. The frequencies of
the mentioned perceptions and treatment goals of patients
with type 1 and type 2 diabetes in answer to open-ended
questions are shown in figure 1. The results of the closed-
ended questions regarding disease perceptions for type 1
and type 2 diabetic patients were shown as median and
interquartile ranges in table 2.
Results were analysed using Intercooled STATA (ver-
sion 8, StataCorp LP, Texas) and Statistica for Windows
(version 6.0, StatSoft, Inc., Tulsa, OK, USA). 
Results
Disease perceptions
The principal component analysis revealed a
one-dimensional solution. The reliability of the
single factor could be considered as high (a = 0.78).
In 74% of all patients, the quality of life was
partially or totally impaired by diabetes. This ef-
fect was more pronounced in patients with type 2
diabetes (89%) than in patients with type 1 diabetes
(overall frequency of type 1 diabetic patients 70%,
table 1). 
As described above, patients were divided in
the following three groups: type 1 diabetic patients
treated with an insulin pump, type 1 diabetic pa-
tients treated without an insulin pump and insulin
treated type 2 diabetic patients. 
In the open-ended questions, patients in all
three groups together were mostly concerned
type 1 diabetes type 2 diabetes
“no insulin pump” “insulin pump”
Number of patients (n) 60 42 22
Gender (m/f) 35/24 15/28 13/9
Age (y) 44 (14) 45 (14) 65 (10)
Diabetes duration (y) 19 (14) 20 (13) 17 (9)
Diabetic complications (%)
No complications 71 61 32
1 complication 15 17 23
2 complicaitons 9 11 23
3 complications 3 11 9
4 complications 2 0 13
Quality of life totally impaired by diabetes (%) 17 20 42
Quality of life partially impaired by diabetes (%) 48 58 47
Data are shown as means (SD)
Table 1
Demographics of
study population.
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Patients’ perceptions
and concerns given
in answer to an open-
ended question. The
perceptions and con-
cerns of type 1 diabe-
tic patients treated
without (type 1 “no
pump”) and with an
insulin pump (type 1
“pump”) and insulin
treated type 2 diabe-
tic patients are
shown in descending
order from left to
right.
about their loss of freedom (frequency of all re-
spondents 24%), dietary restrictions (17%), the
need to measure blood glucose (17%) and about
hypoglycaemia (15%), followed by worries about
loss of efficiency (12%), need for discipline (12%)
and the need to carry around utensils or depend-
ence on a foreign body (12%, figure 1). Women
(data not shown) and patients with insulin pumps
worried especially about hypoglycaemia. Interest-
ingly, none of all patients worried about hyper-
glycemias. Patients treated with insulin pumps
worried very little about dietary restrictions, but a
fourth of them were bothered by their dependence
on a foreign body or their need to carry around
utensils. Patients with type 2 diabetes did not list
the need to measure blood glucose or the fear of
hypoglycaemia as their concerns. 
In the closed-ended questions (table 2), pa-
tients in all three groups together felt mostly con-
cerned about the fear of hypoglycaemia (median
[interquartile range]: 2 [1–4]) and the fear of devel-
oping complications (2 [1.5–3.5]). Patients with
type 1 diabetes, and especially patients treated with
an insulin pump, worried a lot about hypogly-
caemia. Subjects with type 2 diabetes worried more
about dietary restrictions and the need to lose
weight than subjects with type 1 diabetes (median
[interquartile range] 2 [2–3] in type 2 diabetes vs 1
(0–2) in type 1 diabetes and 1.5 (1–3) vs 0 (0–1), re-
spectively). The results were not different when
only the patients who answered to the open-ended
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questions regarding disease perceptions were in-
cluded. 
Treatment goals
The main treatment goal of both type 1 and
type 2 diabetic patients together consisted of keep-
ing a good blood glucose control (frequency of all
respondents: 63%, figure 2A). A less important
goal was the prevention of complications (fre-
quency of all respondents: 27%). Patients treated
with and without insulin pumps had very similar
treatment goals. In contrast, none of the patients
with type 2 diabetes mentioned quality of life or
avoidance of hypoglycaemia as their treatment
goal, while this goal was stated by 29% and 8% of
the patients with type 1 diabetes, respectively. The
following items were mentioned by all respon-
dents in less than 5% of the cases, and thus are not
shown in figure 2A: own control over the disease,
acceptance of diabetes, medical care, discipline,
knowledge, flexibility, independence, avoidance of
injections, nutritional freedom. 
Both type 1 and in type 2 diabetic patients
thought their physicians had goals that were simi-
lar to their own goals (figure 2B). This was espe-
cially apparent in the prevention of complications
or hypoglycaemia. Interestingly, patients with type
2 diabetes thought that their physicians cared more
about their quality of life than they did themselves.
However, patients and physicians judged the
importance of good glucose control differently;
according to the whole group of patients this
aspect was more important for their physicians
(frequency of all respondents: 86%) than for them-
selves. 
Provider satisfaction
Satisfaction with medical care was high. 95%
of all respondents were completely satisfied with
their physicians. 84% of the patients thought that
their physicians knew their treatment goals. 98%
thought that their physicians were responsive to
their needs, 95% that their physicians seemed to
answer their questions, and 97% were convinced
that their physician spent enough time with them.
type 1 diabetes type 2 diabetes
“no insulin pump” “insulin pump“
Hypoglycaemia 2 (1–3) 3 (1–4) 2 (2–2)
Fear of complications 2 (1–4) 2 (1.25–3) 2 (2–4)
Measuring glucose 2 (1–2.25) 2 (0.25–2.75) 2 (2–2)
Injections 2 (0.25–2) 1 (0–2) 2 (1–3)
Personal relations 0 (0–2) 2 (1–2) 2 (0.5–3.5)
Dietary restriction 1 (0–2) 2 (0–2) 2 (2–3)
Need to lose weight 0 (0–0) 0 (0–1) 1.5 (1–3)
Physical activity 0 (0–2) 0 (0–2) 1 (0–1)
Financial concerns 1 (0–2) 1 (0–2) 0.5 (0–4)
Concerns are listed in descending order of overall importance for type 1 diabetic patients treated without 
(type 1 diabetes “no pump”) and with an insulin pump (type 1 diabetes “pump”) and insulin treated type 2 
diabetic patients. The scale ranges from 0 (“does not concern me at all” or “never concerns me”) to 4 
(“concerns me very much” or “always concerns me”). Data are shown as median (interquartile range).
Table 2
Patients’ perceptions
and concerns given
in answer to closed-
ended questions.
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Figure 2
Patients’ treatment
goals (A) and their
perception of their
physicians’ goals (B).
The treatment goals
of type 1 diabetic pa-
tients treated without
(type 1 “no pump”)
and with an insulin
pump (type 1
“pump”) and insulin
treated type 2 dia-
betic patients and of
their physicians are
shown in descending
order from left to
right. 
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This study identified disease perceptions and
treatment goals of type 1 diabetic patients treated
with and without an insulin pump and insulin
treated type 2 diabetic patients. We were also in-
terested whether patients mentioned different
concerns when they are generally asked what their
concerns are, or whether they are guided through
by answering to closed-ended questions and
whether these perceived concerns differed from
their treatment goals. We also wanted to find out
whether patients think that their own treatment
goals differ from those of their physicians. 
When being asked what they perceived gener-
ally as most concerning, type 1 and 2 diabetic pa-
tients mentioned the loss of freedom, the dietary
restrictions and the need to measure blood glu-
cose. When given a list of items, patients were es-
pecially concerned about hypoglycaemia and the
development of complications. In general, dietary
restriction and loss of freedom were less and the
fear of hypoglycaemia was more concerning for
type 1 diabetic patients treated with an insulin
pump. Thus, in open-ended questions, patients
spontaneously worry about their restriction in
their actual quality of life and daily hassles and
mention worries regarding long-term control or
side effects of their treatment after explicit ques-
tioning. The main treatment goals of type 1 and
type 2 diabetic patients focused on long-term goals
like keeping a good blood glucose control. Further
goals were prevention of complications and in type
1 diabetic subjects, but not in type 2 diabetic pa-
tients, the preservation of a good quality of life. Al-
though hypoglycaemia was of substantial concern
for patients, less than half of the type 1 diabetic pa-
tients that were concerned about hypoglycaemia
and none of the type 2 diabetic patients mentioned
the prevention of hypoglycaemia as one of their
main treatment goals. Similarly, patients felt some-
what restricted by their diet, but nutritional free-
dom was mentioned in less than 5% as a treatment
goal. On the other side, patients chose good glu-
cose control as their main goal, but none of them
was concerned by the presence of hyperglycemias.
Patients thought that blood glucose control was
more important for the physicians than for them-
selves.
As we did not find in the literature any vali-
dated questionnaire covering especially treatment
goals or all aspects of disease perceptions, we added
our own questions. The fact that we used open
questions in several items, which were categorised
afterwards could be regarded as a methodological
limitation of the study. However, at the same time
this gave us the possibility to gather more textual
information. Another limitation of our study is
that, due to the small sample size of patients with
type 2 diabetes, we cannot make extensive state-
ments on the differences in perceptions or goals of
patients with type 1 and type 2 diabetes. There
probably also exists a selection bias in our type 2
diabetic patients who had a relatively long du-
ration of illness and suffered from many compli-
cations. In addition, a larger study should clarify 
the impact of confounders like age, sex, level of
education, diabetes duration, number of complica-
tions on disease perceptions and treatment goals in
patients with diabetes.
Disease perceptions
Of specific interest is the finding in our study
that asking an open-ended question yielded differ-
ent results than presenting a list of possible an-
swers. Asked open-ended, patients spontaneously
were more concerned about the restriction of
actual quality of life and daily hassles. Upon more
explicit questioning, patients chose long-term
concerns like the fear of complications as well as
side effects of their treatment like the fear of hy-
poglycaemia as their main concerns. Possibly these
concerns are more in accordance with physicians’
views. These concerns expressed as answers to
closed-ended questions were similar to the results
of other studies that also investigated this topic
with closed-ended questions; a previous survey
performed in patients with type 1 diabetes showed
that 20% of them perceived hypoglycaemia as
worrisome [17]. In another study, type 1 and in-
sulin treated type 2 diabetic patients were reported
to worry predominantly about the development of
complications, and less about hypoglycaemia [16].
In our study, the fear of hypoglycaemia was partic-
ularly pronounced in the patients treated with an
insulin pump. This is most likely a selection bias,
as frequent and especially severe events of hypo-
glycaemia are among the main indications for ther-
apy with an insulin pump in our institution.
Unfortunately, we did not collect information
about the prevalence of mild or severe hypogly-
caemia, as this probably influenced disease percep-
tions. 
Dietary restrictions impaired our participating
subjects consisting of mainly type 1 diabetics only
moderately and even less those type 1 diabetic pa-
tients that were treated with an insulin pump. Most
of our type 1 diabetic patients and all patients
treated with insulin pumps practiced intensified
insulin therapy using meal-adapted multiple injec-
tions, and thus have a more liberalised diet. This
might explain why patients in other studies and our
patients with type 2 diabetes felt their diet restric-
tion to be of greater concern [2, 17]. 
Treatment goals
The main treatment goals of type 1 and type 2
diabetic patients focused on long-term goals like
keeping a good blood glucose control and prevent-
ing complications. Previous data obtained in
patients with type 1 diabetes demonstrated that
stable and low glucose values as well as avoidance
Discussion 
Disease perceptions and treatment goals of diabetic patients 370
of late complications were scored as being very im-
portant, along with flexibility (both dietary flexi-
bility and flexibility in their leisure time), physical
fitness and avoidance of severe hypoglycaemia
[12]. To our knowledge, there are no other pub-
lished studies focusing mainly on the treatment
goals of insulin treated diabetic patients. The few
other studies with an interest in treatment goals in
diabetes do not focus on patients’ treatment goals,
but rather on the differences between doctors’ and
patients’ goals [18, 19]. We found that patients
with type 1 diabetes judged good quality of life to
be more important than patients with type 2 dia-
betes did. This is possibly due to the more dramatic
impact of diabetes on their daily life as well as their
younger age, as we showed that the importance 
of quality of life as a treatment goal appeared to
increase with younger age. 
Patients’ estimates of physicians’ 
treatment goals
There is considerable evidence that the type
and quality of the patient-doctor relationship play
essential roles in achieving set treatment goals [20].
In our study, patient satisfaction was very high and
patients thought that their physicians knew and re-
spected their goals and were responsive to their
needs. According to the patients, physicians had
treatment goals that were similar to their own
goals. This was particularly apparent in the goals
regarding prevention of complications or hypogly-
caemia. Despite this, patients thought that their
physicians valued glucose control more than they
did themselves. Physicians generally tend to over-
value metabolic control [8, 21], and the agreement
between patients’ and physicians’ goals is generally
rather low [18, 19]. Why would physicians overes-
timate the importance of glucose control? One
possibility is that patients as compared to physi-
cians have more additional, possibly more short-
term goals like the actual quality of life. The physi-
cians’ original long-term goal is probably the pre-
vention of complications. However, this issue is
hard to address and is accompanied by a significant
burden like fear about the patient’s reaction. More-
over, such a discussion is time-consuming. Glucose
control or especially HbA1c has become a surro-
gate goal marker for preventing complications in
daily practice, as it is easier and faster to talk about.
However, according to our results, it is tempting
to speculate that for many patients, glucose con-
trol as a goal has become too detached from the
original long-term goal. As management of type 1
and type 2 diabetes is largely relinquished to the
patients in their individual life, their treatment
goals are necessary to be set and known [9]. The
differences between patients’ and presumed physi-
cians’ goals that we and others [19] found stress the
need to actively investigate the patients’ own treat-
ment goals. 
Relationship between disease perception 
and treatment goals
The majority of patients stated that their main
treatment priority was to achieve a good blood
glucose control. Despite this, none of them men-
tioned hyperglycemias as concerning. Hypogly-
caemia was perceived as being very concerning,
and yet, its prevention was only mentioned in 8%
as a treatment goal. Why this discrepancy?
Even when they are told, many patients might
not realise the correlation between poor day-to day
glycaemic control and long-term complications of
the disease. This is all the more difficult, as dia-
betes is a silent disease for a long time.
Both perceptions and concerns are emotional
terms, relate to daily life and rather short-term de-
cisions, while treatment goals relate to the more
cognitive aspects of managing life as a diabetic per-
son, probably also over a longer period of time.
Treatment goals include rather general aspects of
care and are more influenced by health care
provider priorities [22]. Set treatment goals might
also be unrealistic or patients may mention exclu-
sively those goals, which they consider to be able
to actively influence. For example, many patients
feel helpless in avoiding mild hypoglycaemia, as it
is influenced by many uncontrollable minor fac-
tors. 
In general, highly individualised goals that are
in concordance with the patients’ own goals and
short-term behaviour targets are most successful
[23]. To achieve their goals, patients can increase
self-care behaviour to a certain extent by them-
selves [24] and improve glucose control [25]. How-
ever, even when physicians and other health edu-
cators encourage their patients to set their own
treatment goals, this by itself is often not sufficient
to implement most of the behavioural changes that
are necessary to achieve these goals. 
Additional factors like perceptions and con-
cerns influence the attitude and the feeling of re-
sponsibility towards certain behaviour. Together
with motivation and successful coping with stress
situations, they need to be strong enough to over-
come the inconvenience and discomfort that such
behavioural changes involve [9, 26, 27]. Percep-
tions may also represent barriers and inhibit the
achievement of goals [27]. An example for this sit-
uation might be that as long as a patient is con-
cerned about hypoglycaemia, he will avoid low
normal glucose values, even when good glucose
control truly represents this patient’s main treat-
ment goal. Thus, it is necessary to incorporate per-
ceptions to be able to successfully implement the
patients’ treatment goals [16]. 
Our results regarding perceptions, goals and
differences between patients’ and physicians’ goals
are overall in accordance with other published
studies. Nevertheless, our findings should be repli-
cated in larger samples including also diabetic pa-
tients treated in private practices.
In summary, the present exploratory study
identifies the disease perceptions and treatment
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goals of type 1 diabetic patients treated with and
without an insulin pump and insulin treated type
2 diabetic patients. In open-ended questions, pa-
tients spontaneously express concerns about their
actual quality of life and daily hassles and mention
concerns regarding long-term control or side ef-
fects of their treatment after explicit questioning.
For their main treatment goals they choose mainly
long-term goals like glucose control, but still think
that physicians overestimate the importance of
glucose control. 
Thus, this study demonstrates that disease
perceptions might differ depending on how they
are investigated and that they can differ from pa-
tients’ treatment goals. Based on our results, we
propose that both, disease perceptions and treat-
ment goals should be actively searched for in indi-
vidual patients. They should be supported to
bridge the gap between daily concerns and long-
term treatment goals, such as a high quality of life
and good blood glucose control.
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